重組蛋白市場按產品類型、表達系統、應用、最終用戶和地區分類

重組蛋白市場規模預計在 2025 年達到 38.925 億美元，預計到 2032 年將達到 83.397 億美元，2025 年至 2032 年的複合年成長率為 11.5%。

重組蛋白是由重組DNA編碼的蛋白質，該DNA克隆到支持基因表現和傳訊RNA翻譯的表達載體中。透過重組DNA技術進行基因改造可以表現突變蛋白。重組蛋白是天然蛋白質的工程化形式，可以透過多種方式生產，以提高蛋白質產量、改變基因序列並生產有用的商業產品。

許多重組蛋白需要並描述了轉譯後修飾，例如糖基化，而這些修飾僅在真核生物、酵母、哺乳動物或昆蟲細胞培養系統中進行。 HEK293衍生細胞株用於瞬時蛋白生產。目前，大多數重組治療性蛋白質是在哺乳動物細胞中生產的，因為它們能夠生產與自然界中發現的蛋白質類似的高品質蛋白質。此外，許多核准的重組治療性蛋白質是在大腸桿菌中生產的，因為它們具有明確的遺傳結構、快速生長和高產量。

市場動態

該公司正專注於採取收購和合作等策略，以在全球市場奠定堅實的基礎。例如，賽默飛世爾科技於2021年12月收購了重組蛋白開發和製造公司PeproTech。此次收購將增強賽默飛世爾科技的重組蛋白產品組合。

預計在預測期內，重組激素生技藥品許可申請的監管核准將不斷增加，從而推動市場成長。例如，2022年1月，跨國製藥和生物技術公司輝瑞公司和生物技術公司OPKO Health, Inc.宣布，美國食品藥物管理局(FDA)已為其somatrogon的生技藥品許可申請(BLA)簽發了完整反應報告(CRL)。 somatrogon是一種每週一次的長效重組人體生長荷爾蒙，用於治療兒童生長激素缺乏症(GHD)。

本次調查的主要特點

• 本報告對全球重組蛋白市場進行了詳細分析，並以 2024 年為基準年，提供了預測期 2025-2032 的市場規模（百萬美元）和年複合成長率（CAGR%）。
• 它揭示了不同領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 主要公司簡介包括公司亮點、產品系列、關鍵亮點、業績和策略。主要公司包括默克集團 (Merck KGaA)、傲銳東源科技 (OriGene Technologies, Inc.)、Feldan Therapeutics、ACROBiosystems、Abcam plc.、朗道實驗室 (Randox Laboratories Ltd.)、SOL GROUP、Proteintech Group, Inc.、Planet BIoINology Inc. (GenScript)、BTL BIoTechno Labs Pvt Ltd.、Prospec-Tany Technogene Ltd.、BPS Bioscience, Inc.、義翹神州 (Sino Biological)、Cape Bio Pharms、上諾華 (Abnova Corporation) 和 GeNext Genomics。
• 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球重組蛋白市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過分析全球重組蛋白市場所使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章：調查目標和先決條件

• 調查目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖（COM）

第3章：市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 抑制因素
  • 市場吸引力分析
  • 市場機會
• 產品發布
• 合併、收購和合作
• 監理指南與合規性
• 政府干涉
• PEST分析
• 科技
• 品牌屬性映射
• 投資
• 價格分析（2021年）

4. 2020 年至 2032 年全球重組蛋白市場（依產品類型）

• 介紹
• 抗體
• 抗原
• 酵素
• 荷爾蒙
• 其他

5. 2020 年至 2032 年全球重組蛋白市場（依表現系統分類）

• 介紹
• 微生物
• 植物
• 動物

6. 2020 年至 2032 年全球重組蛋白市場應用狀況

• 介紹
• 藥物研發
• 研究應用
• 治療用途
• 診斷
• 其他

7. 2020 年至 2032 年全球重組蛋白市場（依最終用戶分類）

• 介紹
• 生物技術和製藥公司
• 學術研究機構
• 合約研究組織
• 其他

8. 2020 年至 2032 年全球重組蛋白市場（按地區）

• 介紹
• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 東南亞國協
  • 澳洲
  • 韓國
  • 其他亞太地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭態勢

• Merck KGaA
• OriGene Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Feldan Therapeutics
• ACROBiosystems
• Abcam plc.
• Randox Laboratories Ltd.
• SOL GROUP
• Proteintech Group, Inc
• Planet BIoTechnology, Inc.
• INFINITE ENZYMES, INC.
• ORF Genetics
• GenScript
• BTL BIoTechno Labs Pvt Ltd.
• Prospec-Tany Technogene Ltd.
• BPS Bioscience, Inc.
• Sino Biological
• Cape Bio Pharms
• Abnova Corporation
• GeNext Genomics

第 10 章 章節

• 調查方法
• 關於出版商

Recombinant Protein Market is estimated to be valued at USD 3,892.5 Mn in 2025 and is expected to reach USD 8,339.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.

A recombinant protein is a protein encoded by recombinant DNA cloned into an expression vector that supports gene expression and translation of messenger RNA. Modification of genes by recombinant DNA techniques can result in the expression of mutant proteins. Recombinant proteins are engineered forms of natural proteins that are produced in a variety of ways to increase protein production, alter genetic sequences, and produce useful commodities.

Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high quality proteins similar to those in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.

Market Dynamics

The company is focused on adopting strategies such as acquisitions and collaborations to gain strong foothold in the global market. For instance, in December, 2021, Thermo Fischer Scientific Inc. acquired PeproTech, Inc., which is a developer and manufacturer of recombinant proteins. This acquisition will help Thermo Fischer Scientific Inc. to strengthen its recombinant proteins portfolio.

The increasing approvals for the biologics license application of recombinant hormones from the regulatory bodies is expected to drive the market growth over the forecast period. For instance, in January 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology Company, and OPKO Health, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients.

Key features of the study

• This report provides in-depth analysis of the global recombinant protein market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global recombinant protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Merck KGaA, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., Feldan Therapeutics, ACROBiosystems, Abcam plc., Randox Laboratories Ltd., SOL GROUP, Proteintech Group, Inc, Planet Biotechnology, Inc., INFINITE ENZYMES, INC., ORF Genetics, GenScript, BTL Biotechno Labs Pvt Ltd., Prospec-Tany Technogene Ltd., BPS Bioscience, Inc., Sino Biological, Cape Bio Pharms, Abnova Corporation, GeNext Genomics.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global recombinant protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global recombinant protein market.

Market Segmentation

• Global Recombinant Protein Market, By Product Type
  • Antibodies
  • Antigens
  • Enzymes
  • Hormones
  • Others
• Global Recombinant Protein Market, By Expression System
  • Microbes
  • Plant
  • Animal
• Global Recombinant Protein Market By Application
  • Drug Discovery and Development
  • Research Application
  • Therapeutic Use
  • Diagnostics
  • Others
• Global Recombinant Protein Market By End User
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institute
  • Contract Research Organization
  • Others
• Global Recombinant Protein Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Merck KGaA
  • OriGene Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Feldan Therapeutics
  • ACROBiosystems
  • Abcam plc.
  • Randox Laboratories Ltd.
  • SOL GROUP
  • Proteintech Group, Inc
  • Planet Biotechnology, Inc.
  • INFINITE ENZYMES, INC.
  • ORF Genetics
  • GenScript
  • BTL Biotechno Labs Pvt Ltd.
  • Prospec-Tany Technogene Ltd.
  • BPS Bioscience, Inc.
  • Sino Biological
  • Cape Bio Pharms
  • Abnova Corporation
  • GeNext Genomics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Expression System
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Government Intervention
• PEST Analysis
• Technology Landscape
• Brand Attribute Mapping
• Investments
• Pricing Analysis (2021)

4. Global Recombinant Protein Market, By Product Type, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Antibodies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Antigens
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Enzymes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Hormones
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Recombinant Protein Market, By Expression System, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Microbes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Plant
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Animal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Recombinant Protein Market, By Application, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segments Trends
• Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Research Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Therapeutic Use
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Recombinant Protein Market, By End User, 2020 - 2032, (USD Mn

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segments Trends
• Biotechnology and Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Recombinant Protein Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Expression System, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OriGene Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Feldan Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ACROBiosystems
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abcam plc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Randox Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• SOL GROUP
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Proteintech Group, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Planet Biotechnology, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• INFINITE ENZYMES, INC.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ORF Genetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GenScript
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BTL Biotechno Labs Pvt Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Prospec-Tany Technogene Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BPS Bioscience, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sino Biological
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cape Bio Pharms
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abnova Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GeNext Genomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us